149 related articles for article (PubMed ID: 11438649)
21. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
[TBL] [Abstract][Full Text] [Related]
22. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
Scholl T; Mahanta SK; Strominger JL
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
[TBL] [Abstract][Full Text] [Related]
23. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
Schnappauf F; Hake SB; Camacho Carvajal MM; Bontron S; Lisowska-Grospierre B; Steimle V
Eur J Immunol; 2003 Aug; 33(8):2337-47. PubMed ID: 12884309
[TBL] [Abstract][Full Text] [Related]
24. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
25. The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.
Muhlethaler-Mottet A; Krawczyk M; Masternak K; Spilianakis C; Kretsovali A; Papamatheakis J; Reith W
J Biol Chem; 2004 Sep; 279(39):40529-35. PubMed ID: 15271997
[TBL] [Abstract][Full Text] [Related]
26. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.
Mudhasani R; Fontes JD
Mol Cell Biol; 2002 Jul; 22(14):5019-26. PubMed ID: 12077331
[TBL] [Abstract][Full Text] [Related]
27. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32.
Fontes JD; Jiang B; Peterlin BM
Nucleic Acids Res; 1997 Jun; 25(12):2522-8. PubMed ID: 9171108
[TBL] [Abstract][Full Text] [Related]
28. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
29. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
30. Function and regulation of class II transactivator in the immune system.
Chang CH; Gourley TS; Sisk TJ
Immunol Res; 2002; 25(2):131-42. PubMed ID: 11999167
[TBL] [Abstract][Full Text] [Related]
31. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
32. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy.
Bontron S; Ucla C; Mach B; Steimle V
Mol Cell Biol; 1997 Aug; 17(8):4249-58. PubMed ID: 9234682
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250.
Raval A; Howcroft TK; Weissman JD; Kirshner S; Zhu XS; Yokoyama K; Ting J; Singer DS
Mol Cell; 2001 Jan; 7(1):105-15. PubMed ID: 11172716
[TBL] [Abstract][Full Text] [Related]
34. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.
Zhou H; Glimcher LH
Immunity; 1995 May; 2(5):545-53. PubMed ID: 7749985
[TBL] [Abstract][Full Text] [Related]
35. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator.
Kretsovali A; Agalioti T; Spilianakis C; Tzortzakaki E; Merika M; Papamatheakis J
Mol Cell Biol; 1998 Nov; 18(11):6777-83. PubMed ID: 9774691
[TBL] [Abstract][Full Text] [Related]
36. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y
Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904
[TBL] [Abstract][Full Text] [Related]
37. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants.
Chin KC; Li GG; Ting JP
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2501-6. PubMed ID: 9122224
[TBL] [Abstract][Full Text] [Related]
38. Binding and cooperative interactions between two B cell-specific transcriptional coactivators.
Fontes JD; Jabrane-Ferrat N; Toth CR; Peterlin BM
J Exp Med; 1996 Jun; 183(6):2517-21. PubMed ID: 8676072
[TBL] [Abstract][Full Text] [Related]
39. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
[TBL] [Abstract][Full Text] [Related]
40. Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.
Kohoutek J; Blazek D; Peterlin BM
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17349-54. PubMed ID: 17088550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]